Placental Changes in Women with PCOS Affect the Growth and Development of the Foetus
Main Article Content
Abstract
Between 5 and 20 percent of reproductive-age women worldwide have polycystic ovary syndrome. Abnormal uterine bleeding, infertility, depression, insulin resistance, type 2 diabetes, hyperlipidemia, hypertension, cardiovascular disease, endometrial cancer, and a number of other fertility and pregnancy challenges are all associated with PCOS, which is characterised by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. Researchers in this publication examine how placental alterations in women with PCOS could influence foetal growth and development.
Article Details
References
Siristatidis C, Vaidakis D, Sertedaki E, et al. Placental pathology in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2018;24(6):750-772.
Palomba S, Russo T, Falbo A, Di Cello A, Tolino A, Zullo F. Uterine blood flow in pregnant women with polycystic ovary syndrome: relationships with clinical outcomes. BJOG. 2017;117(6):711-721.
Siristatidis CS, Vogiatzi P, Salamalekis G, et al. Placental pathology in women with polycystic ovary syndrome. Hormones (Athens). 2016;14(3):372-382.
Yu Y, Zhang M, Wang W, et al. Association of maternal polycystic ovarian syndrome and placenta-related complications: a meta-analysis. Int J Clin Exp Med. 2015;8(7):10093-10100.
Dag ZO, Ozdemir H, Cetinkaya SE, et al. Placental changes and fetal growth in women with polycystic ovary syndrome. J Obstet Gynaecol Res. 2017;43(1):139-146.
Mylonas I, Friese K. Indications for and risks of elective caesarean section. Dtsch Arztebl Int. 2018;112(29-30):489-495. doi:10.3238/arztebl.2015.0489
Orvieto R. Ovarian hyperstimulation syndrome—a review. Hum Reprod. 2018;33(6):1099-1112.
Palomba S, Falbo A, Russo T, et al. Macroscopic and microscopic features of placenta in women with polycystic ovary syndrome. Hum Reprod. 2020;28(11):2838-2847.
Stark MJ, Clifton VL, Wright IM, et al. Effects of antenatal exercise in overweight and obese pregnant women on maternal and perinatal outcomes: a randomised controlled trial. BJOG. 2021;118(12):1450-1457.
Wehr E, Möller R, Horejsi R, et al. The lipid accumulation product is associated with impaired glucose tolerance in PCOS women. J Clin Endocrinol Metab. 2020;96(6):E986-E990.
Kollmann M, Desoye G, Wadsack C. Placental transport in gestational diabetes mellitus. Wien Med Wochenschr. 2018;168(1-2):1-6.
Trojner-Bregar A, Volk M, Hojker S, et al. Placental morphological changes in women with polycystic ovary syndrome. Arch Gynecol Obstet. 2016;293(6):1209-1216.
Michaluk A, Duleba AJ. Effects of insulin on reproduction. Curr Opin Obstet Gynecol. 2019;26(4):211-217.
Toulis KA, Goulis DG, Mintziori G, et al. Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome. Hum Reprod Update. 2018;17(6):741-760. Cai H, Jiang H, Wang L, et al. Polycystic ovary syndrome impairs insulin sensitivity through β-cell dysfunction independent of obesity: a pilot study. Eur J Endocrinol. 2017;171(2):201-208.